Balchem Corporation

Informe acción NasdaqGS:BCPC

Capitalización de mercado: US$5.2b

Balchem Crecimiento futuro

Future controles de criterios 1/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Balchem de 6.7% y 5.1% respectivamente, mientras que el BPA crecerá en un 5.9% al año.

Información clave

6.7%

Tasa de crecimiento de los beneficios

5.94%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals18.2%
Tasa de crecimiento de los ingresos5.1%
Rentabilidad financiera futuran/a
Cobertura de analistas

Low

Última actualización01 May 2026

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Balchem: An Attractive Valuation Makes This Stock A Buy

Mar 27

Long-Term Nutrition And Health Trends Will Support Stronger Margins And Earnings Potential

Catalysts About Balchem Balchem supplies specialty nutrients and ingredients for human, animal and plant health, along with performance gases and related solutions. What are the underlying business or industry changes driving this perspective?

Encapsulation Investments And International Expansion Will Shape Balanced Future For Nutrition Specialist

Catalysts About Balchem Balchem produces specialty nutrition and ingredient solutions for human, animal and plant health, along with performance gases. What are the underlying business or industry changes driving this perspective?

BCPC: Dividend Increase And Buyback Program Will Support Steady Future Returns

Analysts kept their Balchem fair value estimate broadly steady at $191, pointing to only very small tweaks in assumptions such as discount rate, long term revenue growth, profit margin and future P/E as the basis for maintaining their target level. What's in the News On December 9, 2025, Balchem Corporation's Board of Directors declared an annual dividend of $0.96 per share, payable on January 20, 2026, to stockholders of record as of December 23, 2025.

If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity

Feb 15
If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity

BCPC: Share Repurchases And Higher Dividend Will Support Attractive Future Returns

Analysts have maintained their fair value estimate for Balchem at US$191. They have made only minimal adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions, indicating that their overall view on the stock's valuation drivers remains essentially unchanged.

Is Now An Opportune Moment To Examine Balchem Corporation (NASDAQ:BCPC)?

Feb 01
Is Now An Opportune Moment To Examine Balchem Corporation (NASDAQ:BCPC)?

BCPC: Share Repurchases And Rising Dividend Will Support Attractive Future Returns

Analysts have maintained their Balchem fair value estimate at US$191, with only small tweaks to the discount rate, revenue growth, profit margin, and forward P/E assumptions. This reflects a largely unchanged view on the stock's risk and earnings profile.

BCPC: Share Repurchases And Dividend Increases Will Support Attractive Future Returns

Analysts kept their fair value estimate for Balchem steady at US$191, pointing to only very small model tweaks in the discount rate, revenue growth, margin and forward P/E assumptions rather than any change in their overall view of the company. What's in the News Balchem Corporation announced a share repurchase program authorizing the company to buy back up to 4,000,000 shares, with no expiration date on the program (Key Developments).

BCPC: Share Repurchases And Dividend Increases Will Drive Attractive Future Returns

Analysts have maintained their price target on Balchem at approximately $191.00. This reflects only marginal tweaks to underlying assumptions such as discount rate, revenue growth, and profit margin, rather than a material change in their outlook.

BCPC: Share Repurchases Will Support Attractive Long Term Return Potential

Analysts have lowered their price target on Balchem by approximately $9 to about $191 per share, reflecting more cautious assumptions around revenue growth and profit margins, even though long term valuation multiples are slightly higher. What's in the News Completed a long running share repurchase program, buying back a total of 3,475,622 shares, or about 12.76% of shares outstanding, for approximately $190.58 million since the authorization began in 1999 (Key Developments) During the most recent quarter from July 1, 2025 to September 30, 2025, repurchased 95,760 shares, roughly 0.3% of shares outstanding, for $15.42 million as the final tranche under the existing buyback plan (Key Developments) Valuation Changes The Fair Value Estimate has fallen modestly from about $200.33 to $191.00 per share, reflecting a slightly more conservative outlook.

Balchem (NASDAQ:BCPC) Is Experiencing Growth In Returns On Capital

Dec 01
Balchem (NASDAQ:BCPC) Is Experiencing Growth In Returns On Capital

Some Shareholders Feeling Restless Over Balchem Corporation's (NASDAQ:BCPC) P/E Ratio

Oct 10
Some Shareholders Feeling Restless Over Balchem Corporation's (NASDAQ:BCPC) P/E Ratio

Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Sep 26
Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Aug 26
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital

Jul 21
Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

Jun 23
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

When Should You Buy Balchem Corporation (NASDAQ:BCPC)?

May 26
When Should You Buy Balchem Corporation (NASDAQ:BCPC)?

Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

May 12
Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Balchem's Q3 Shows Record Earnings And Valuation Pressure

Oct 28
User avatar

Innovating In Nutrition And Health Sectors Drives Strong Financial Growth And Market Expansion

Launch of Optifolin+ in the nutrition segment and strong Human Nutrition & Health sales indicate potential for market share expansion and sustained revenue growth.

Balchem: A Tale Of Two Businesses

May 10

Balchem: Potential Turnaround Is In The Price

Feb 21

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:BCPC - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20281,215N/AN/AN/A1
12/31/20271,1561782102434
12/31/20261,0901732012441
3/31/20261,057158176220N/A
12/31/20251,037155173217N/A
9/30/20251,014149162202N/A
6/30/2025986143153187N/A
3/31/2025965137151185N/A
12/31/2024954128146182N/A
9/30/2024942122162197N/A
6/30/2024932117159192N/A
3/31/2024930115147182N/A
12/31/2023922109146184N/A
9/30/2023926103118158N/A
6/30/202394199106153N/A
3/31/202394699117166N/A
12/31/202294210589139N/A
9/30/202292310991141N/A
6/30/202287710995139N/A
3/31/202284210286127N/A
12/31/202179996123161N/A
9/30/202176793128164N/A
6/30/202174490125160N/A
3/31/202171588134169N/A
12/31/202070485117150N/A
9/30/202068983108136N/A
6/30/202067382116143N/A
3/31/20206618199125N/A
12/31/201964480N/A124N/A
9/30/201964180N/A131N/A
6/30/201963778N/A121N/A
3/31/201963978N/A116N/A
12/31/201864479N/A119N/A
9/30/2018639100N/A110N/A
6/30/201863597N/A112N/A
3/31/201861894N/A113N/A
12/31/201759590N/A111N/A
9/30/201757664N/A107N/A
6/30/201756462N/A97N/A
3/31/201755660N/A101N/A
12/31/201655356N/A108N/A
9/30/201654556N/A105N/A
6/30/201654756N/A110N/A
3/31/201654356N/A107N/A
12/31/201555260N/A104N/A
9/30/201558263N/A115N/A
6/30/201560364N/A108N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (6.7% al año) de BCPC es superior a la tasa de ahorro (3.4%).

Beneficios vs. Mercado: Se prevé que los beneficios (6.7% al año) de BCPC crezcan menos que el mercado US (16% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de BCPC crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (5.1% al año) de BCPC crezcan más despacio que el mercado de US (11.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 5.1% al año) de BCPC crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de BCPC se prevé que sea elevada dentro de 3 años.

Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/03 15:44
Precio de las acciones al final del día2026/05/01 00:00
Beneficios2026/03/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Balchem Corporation está cubierta por 9 analistas. 4 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Robert LabickCJS Securities, Inc.
Timothy RameyD.A. Davidson & Co.
Raghuram SelvarajuH.C. Wainwright & Co.